Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens aims to alleviate holiday shopping stress with extended Same Day Delivery and Pickup services available nationwide. Customers can order up to 7 PM for delivery within an hour on Christmas Eve and Day, with adjusted hours on those days. Stores will operate on regular hours on Christmas Eve and adjusted hours from 9 AM to 6 PM on Christmas Day. Additionally, Walgreens promotes affordable gift options under $20, and is partnering with Mental Health America for donations through the holiday season, matching up to $500,000 of public contributions.
Walgreens Boots Alliance (WBA) and VillageMD have announced a significant expansion into San Antonio, Texas, with plans to open nine Village Medical at Walgreens primary care practices over the next year. This initiative marks their entry into the fifth major Texas market, following Houston, El Paso, Austin, and Dallas. The coordinated care model aims to provide comprehensive services, addressing chronic health conditions that account for 75% of Texas's healthcare expenditures. The expansion will create over 850 full-time jobs, with 380 positions for STEM professionals.
Walgreens Boots Alliance (NASDAQ: WBA) is set to announce its fiscal 2022 first quarter earnings on January 6, 2022, at 7 a.m. Eastern Time. A conference call will follow at 8:30 a.m. Eastern Time. Investors can access the call via the WBA investor relations website and will have the option to listen to a replay for up to 12 months. WBA continues to position itself as a leader in integrated pharmacy, healthcare, and retail, with approximately 13,000 locations worldwide and over 315,000 team members.
Walgreens, in collaboration with Western Dental & Orthodontics and the Southern California Chapter of NFL Alumni, will offer free COVID vaccinations at a Holiday Block Party on December 4, from 11 a.m. to 3 p.m. in Santa Ana, California. The event provides free COVID vaccines, boosters, and flu shots to individuals aged 5 and older. Notable attendees include NFL alumni James Washington and Jarrod Bunch. The initiative aims to increase vaccination rates in Southern California as part of ongoing pandemic efforts.
Walgreens Boots Alliance (WBA) has announced its agreement to acquire the remaining 30% share of its joint venture with McKesson Corporation (MCK) in Germany, making WBA the sole owner of GEHE Pharma Handel and Alliance Healthcare Deutschland. This acquisition is part of McKesson's strategy to fully exit the European market. The transaction's financial terms were not disclosed and are subject to regulatory approval. This move aims to strengthen WBA's presence in the German pharmaceutical distribution market.
Walgreens Boots Alliance (WBA) will have CEO Roz Brewer and CFO James Kehoe speak at the 4th Annual Evercore ISI HealthCONx Virtual Conference on November 29 at 5:00 p.m. ET. The event will be accessible via WBA's investor relations website, providing insights into the company's role in healthcare and retail.
WBA operates around 13,000 locations globally and employs over 315,000 team members. They focus on improving healthcare access and sustainability, as noted by their inclusion in the Dow Jones Sustainability Indices.
Walgreens has announced that individuals over 18 can now receive COVID-19 vaccine boosters from Pfizer, Moderna, or Johnson & Johnson at stores nationwide. This follows the FDA's recent expansion of Emergency Use Authorization for these vaccines. Appointments can be scheduled through the Walgreens app or website, enhancing accessibility for communities during the holiday season. The CDC recommends boosters for those eligible based on their prior vaccination history. Walgreens continues to prioritize health services across its nearly 9,000 locations.
Walgreens has announced that members of its Prescription Savings Club can save up to 80% on long-acting insulins, specifically Insulin Glargine (insulin glargine-yfgn), co-developed with Viatris and Biocon Biologics. The insulin will cost $71.99 for a vial and $84.99 for a box of five pens. Increasing insulin prices have led many diabetics to reduce or skip doses; therefore, this initiative aims to improve access and adherence among those uninsured or underinsured, benefiting over 34 million adults with diabetes in the U.S.
Summary not available.
Walgreens Boots Alliance (WBA) and VillageMD are set to open over 20 new primary care practices in the Dallas area, marking their expansion into Texas's fourth major market. The first location opened on October 26, with several more to follow. This initiative aims to provide accessible healthcare, particularly for chronic disease patients, as Texas currently ranks poorly in primary care access. By 2027, the companies plan to launch 1,000 primary care practices, with many located in underserved areas, enhancing community healthcare services.